Laboratory Overview
Afilta 20 Zentiva is a phosphodiesterase type 5 (PDE5) inhibitor containing 20mg tadalafil citrate per tablet, manufactured by Zentiva under pharmaceutical quality standards. This compound demonstrates selective inhibition of PDE5 enzyme activity, making it valuable for investigating cyclic guanosine monophosphate (cGMP) signalling pathways and vascular endothelial function in controlled laboratory environments. Research teams at Stroid UK Shop frequently examine tadalafil’s molecular mechanisms in vascular biology studies.
Research Applications
Tadalafil citrate enables comprehensive evaluation of nitric oxide-cGMP signalling cascades and smooth muscle relaxation mechanisms. Researchers investigate its prolonged half-life characteristics compared to other PDE5 inhibitors, examining enzyme kinetics and tissue selectivity patterns. Studies focus on endothelial dysfunction models, pulmonary arterial pressure regulation, and cellular calcium homeostasis mechanisms. The compound’s unique pharmacokinetic profile makes it suitable for extended observation periods in tadalafil research protocols. Laboratory investigations examine its interaction with other vasodilatory compounds and cardiovascular research models. Advanced research teams studying selective modulators often incorporate tadalafil studies to understand receptor selectivity patterns. Additionally, peptide research laboratories examine potential synergistic effects with vasoactive compounds.
Laboratory Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Tadalafil Citrate |
| Strength | 20mg per tablet |
| Manufacturer | Zentiva |
| CAS Number | 171596-29-5 |
| Molecular Formula | C₂₂H₁₉N₃O₄ · C₆H₈O₇ |
| Molecular Weight | 581.59 g/mol |
| Storage | Room temperature, dry environment |
Research Compliance
Afilta 20 Zentiva is supplied exclusively for in-vitro research purposes and laboratory investigations. This product is not intended for human consumption, therapeutic use, or clinical applications. Researchers must ensure proper handling protocols and laboratory safety standards when conducting studies with this compound. All research applications must comply with applicable regulations and institutional guidelines for pharmaceutical research materials.
